 |
PDBsum entry 1vcc
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
2:767-777
(1994)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the amino-terminal fragment of vaccinia virus DNA topoisomerase I at 1.6 A resolution.
|
|
A.Sharma,
R.Hanai,
A.Mondragón.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: Vaccinia virus, a cytoplasmically-replicating poxvirus, encodes a
type I DNA topoisomerase that is biochemically similar to eukaryotic-like DNA
topoisomerases I, and which has been widely studied as a model topoisomerase. It
is the smallest topoisomerase known and is unusual in that it is resistant to
the potent chemotherapeutic agent camptothecin. RESULTS: The crystal structure
of a 9 kDa amino-terminal fragment of vaccinia virus DNA topoisomerase I has
been determined at 1.6 A resolution. The fragment forms a five-stranded,
antiparallel beta-sheet with two short alpha-helices and connecting loops.
Residues that are conserved between all eukaryotic-like type I topoisomerases
are not clustered in particular regions of the structure. CONCLUSIONS: This is
the first atomic structure of any region of a eukaryotic-like DNA topoisomerase
I. It has provided insights into the structural bases of the phenotypes of some
single-site mutants of the intact topoisomerase. The structure has enabled us to
study the interactions within a well-folded protein fragment and the
camptothecin resistance of the viral topoisomerase.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Electron density maps of vaccinia virus DNA
topoisomerase I. (a) The original MIRAS map to 2.8 å used
for tracing the amino-terminal fragment. The map is contoured at
1.0 σ. (b) 2F[o]– F[c] map at 1.6 å resolution of the
cryo-cooled protein model, contoured at 1.2σ. Figure 2.
Electron density maps of vaccinia virus DNA topoisomerase I. (a)
The original MIRAS map to 2.8 å used for tracing the
amino-terminal fragment. The map is contoured at 1.0 σ. (b)
2F[o]– F[c] map at 1.6 å resolution of the cryo-cooled
protein model, contoured at 1.2σ.
|
 |
Figure 4.
Figure 4. Stereo view of the hydrophobic core in the amino
terminal fragment of vaccinia virus DNA topoisomerase I. The
ribbon diagram is shown in blue. All hydrophobic residues are
colored yellow, and hydrophilic residues in orange. The view is
looking down the core with the sheet on the right and the
helices on the left bottom. Figure 4. Stereo view of the
hydrophobic core in the amino terminal fragment of vaccinia
virus DNA topoisomerase I. The ribbon diagram is shown in blue.
All hydrophobic residues are colored yellow, and hydrophilic
residues in orange. The view is looking down the core with the
sheet on the right and the helices on the left bottom.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Structure
(1994,
2,
767-777)
copyright 1994.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.Van Vliet,
M.R.Mohamed,
L.Zhang,
N.Y.Villa,
S.J.Werden,
J.Liu,
and
G.McFadden
(2009).
Poxvirus proteomics and virus-host protein interactions.
|
| |
Microbiol Mol Biol Rev,
73,
730-749.
|
 |
|
|
|
|
 |
N.M.Baker,
R.Rajan,
and
A.Mondragón
(2009).
Structural studies of type I topoisomerases.
|
| |
Nucleic Acids Res,
37,
693-701.
|
 |
|
|
|
|
 |
A.Patel,
S.Shuman,
and
A.Mondragón
(2006).
Crystal structure of a bacterial type IB DNA topoisomerase reveals a preassembled active site in the absence of DNA.
|
| |
J Biol Chem,
281,
6030-6037.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Fan,
and
A.E.Mark
(2006).
Mimicking the action of GroEL in molecular dynamics simulations: application to the refinement of protein structures.
|
| |
Protein Sci,
15,
441-448.
|
 |
|
|
|
|
 |
K.Perry,
Y.Hwang,
F.D.Bushman,
and
G.D.Van Duyne
(2006).
Structural basis for specificity in the poxvirus topoisomerase.
|
| |
Mol Cell,
23,
343-354.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.D.Grindley,
K.L.Whiteson,
and
P.A.Rice
(2006).
Mechanisms of site-specific recombination.
|
| |
Annu Rev Biochem,
75,
567-605.
|
 |
|
|
|
|
 |
Y.Hwang,
N.Minkah,
K.Perry,
G.D.Van Duyne,
and
F.D.Bushman
(2006).
Regulation of catalysis by the smallpox virus topoisomerase.
|
| |
J Biol Chem,
281,
38052-38060.
|
 |
|
|
|
|
 |
F.Moreno-Herrero,
L.Holtzer,
D.A.Koster,
S.Shuman,
C.Dekker,
and
N.H.Dekker
(2005).
Atomic force microscopy shows that vaccinia topoisomerase IB generates filaments on DNA in a cooperative fashion.
|
| |
Nucleic Acids Res,
33,
5945-5953.
|
 |
|
|
|
|
 |
H.Fan,
and
A.E.Mark
(2004).
Refinement of homology-based protein structures by molecular dynamics simulation techniques.
|
| |
Protein Sci,
13,
211-220.
|
 |
|
|
|
|
 |
H.Fan,
and
A.E.Mark
(2004).
Mimicking the action of folding chaperones in molecular dynamics simulations: Application to the refinement of homology-based protein structures.
|
| |
Protein Sci,
13,
992-999.
|
 |
|
|
|
|
 |
K.D.Corbett,
and
J.M.Berger
(2004).
Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases.
|
| |
Annu Rev Biophys Biomol Struct,
33,
95.
|
 |
|
|
|
|
 |
H.Fan,
and
A.E.Mark
(2003).
Relative stability of protein structures determined by X-ray crystallography or NMR spectroscopy: a molecular dynamics simulation study.
|
| |
Proteins,
53,
111-120.
|
 |
|
|
|
|
 |
L.Yakovleva,
L.Tian,
J.M.Sayer,
G.P.Kalena,
H.Kroth,
D.M.Jerina,
and
S.Shuman
(2003).
Site-specific DNA transesterification by vaccinia topoisomerase: effects of benzo[alpha]pyrene-dA, 8-oxoguanine, 8-oxoadenine and 2-aminopurine modifications.
|
| |
J Biol Chem,
278,
42170-42177.
|
 |
|
|
|
|
 |
A.Das,
C.Mandal,
A.Dasgupta,
T.Sengupta,
and
H.K.Majumder
(2002).
An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani.
|
| |
Nucleic Acids Res,
30,
794-802.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.O.Krogh,
and
S.Shuman
(2002).
A poxvirus-like type IB topoisomerase family in bacteria.
|
| |
Proc Natl Acad Sci U S A,
99,
1853-1858.
|
 |
|
|
|
|
 |
J.J.Champoux
(2001).
DNA topoisomerases: structure, function, and mechanism.
|
| |
Annu Rev Biochem,
70,
369-413.
|
 |
|
|
|
|
 |
M.R.Redinbo,
J.J.Champoux,
and
W.G.Hol
(2000).
Novel insights into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA.
|
| |
Biochemistry,
39,
6832-6840.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.R.Redinbo,
J.J.Champoux,
and
W.G.Hol
(1999).
Structural insights into the function of type IB topoisomerases.
|
| |
Curr Opin Struct Biol,
9,
29-36.
|
 |
|
|
|
|
 |
Y.Hwang,
A.Burgin,
and
F.Bushman
(1999).
DNA contacts stimulate catalysis by a poxvirus topoisomerase.
|
| |
J Biol Chem,
274,
9160-9168.
|
 |
|
|
|
|
 |
C.Cheng,
P.Kussie,
N.Pavletich,
and
S.Shuman
(1998).
Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases.
|
| |
Cell,
92,
841-850.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Cheng,
and
S.Shuman
(1998).
A catalytic domain of eukaryotic DNA topoisomerase I.
|
| |
J Biol Chem,
273,
11589-11595.
|
 |
|
|
|
|
 |
C.L.Hann,
A.L.Carlberg,
and
M.A.Bjornsti
(1998).
Intragenic suppressors of mutant DNA topoisomerase I-induced lethality diminish enzyme binding of DNA.
|
| |
J Biol Chem,
273,
31519-31527.
|
 |
|
|
|
|
 |
J.M.Berger
(1998).
Structure of DNA topoisomerases.
|
| |
Biochim Biophys Acta,
1400,
3.
|
 |
|
|
|
|
 |
M.R.Redinbo,
L.Stewart,
P.Kuhn,
J.J.Champoux,
and
W.G.Hol
(1998).
Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA.
|
| |
Science,
279,
1504-1513.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Hwang,
B.Wang,
and
F.D.Bushman
(1998).
Molluscum contagiosum virus topoisomerase: purification, activities, and response to inhibitors.
|
| |
J Virol,
72,
3401-3406.
|
 |
|
|
|
|
 |
J.Sekiguchi,
and
S.Shuman
(1997).
Mutational analysis of vaccinia virus topoisomerase identifies residues involved in DNA binding.
|
| |
Nucleic Acids Res,
25,
3649-3656.
|
 |
|
|
|
|
 |
J.Wittschieben,
and
S.Shuman
(1997).
Mechanism of DNA transesterification by vaccinia topoisomerase: catalytic contributions of essential residues Arg-130, Gly-132, Tyr-136 and Lys-167.
|
| |
Nucleic Acids Res,
25,
3001-3008.
|
 |
|
|
|
|
 |
L.K.Wang,
J.Wittschieben,
and
S.Shuman
(1997).
Mutational analysis of 26 residues of vaccinia DNA topoisomerase identifies Ser-204 as important for DNA binding and cleavage.
|
| |
Biochemistry,
36,
7944-7950.
|
 |
|
|
|
|
 |
L.K.Wang,
and
S.Shuman
(1997).
Deletions at the carboxyl terminus of vaccinia DNA topoisomerase affect DNA binding and enhance distributivity in DNA relaxation.
|
| |
Biochemistry,
36,
3909-3916.
|
 |
|
|
|
|
 |
A.E.Hodel,
P.D.Gershon,
X.Shi,
and
F.A.Quiocho
(1996).
The 1.85 A structure of vaccinia protein VP39: a bifunctional enzyme that participates in the modification of both mRNA ends.
|
| |
Cell,
85,
247-256.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Maxwell
(1996).
Protein gates in DNA topoisomerase II.
|
| |
Nat Struct Biol,
3,
109-112.
|
 |
|
|
|
|
 |
J.Sekiguchi,
N.C.Seeman,
and
S.Shuman
(1996).
Resolution of Holliday junctions by eukaryotic DNA topoisomerase I.
|
| |
Proc Natl Acad Sci U S A,
93,
785-789.
|
 |
|
|
|
|
 |
J.Sekiguchi,
and
S.Shuman
(1996).
Identification of contacts between topoisomerase I and its target DNA by site-specific photocrosslinking.
|
| |
EMBO J,
15,
3448-3457.
|
 |
|
|
|
|
 |
A.Sharma,
and
A.Mondragón
(1995).
DNA topoisomerases.
|
| |
Curr Opin Struct Biol,
5,
39-47.
|
 |
|
|
|
|
 |
N.Lue,
A.Sharma,
A.Mondragón,
and
J.C.Wang
(1995).
A 26 kDa yeast DNA topoisomerase I fragment: crystallographic structure and mechanistic implications.
|
| |
Structure,
3,
1315-1322.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Hanai,
and
J.C.Wang
(1994).
Protein footprinting by the combined use of reversible and irreversible lysine modifications.
|
| |
Proc Natl Acad Sci U S A,
91,
11904-11908.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |